Cardio- and cerebrovascular risk with conventional synthetic disease-modifying antirheumatic drugs (CSDMARDS) in rheumatic arthritis (RA): a real-world comparative assesment
| Main Authors: | , , , , , , , , , |
|---|---|
| Format: | Conference item |
| Published: |
2020
|
| _version_ | 1797051070361370624 |
|---|---|
| author | Prats-Uribe, A Illingens, B Vizcaya, D Weaver, J Burn, E Sawant, R Marinier, K Ryan, P Prieto-Alhambra, D European Hlth Data Evidence |
| author_facet | Prats-Uribe, A Illingens, B Vizcaya, D Weaver, J Burn, E Sawant, R Marinier, K Ryan, P Prieto-Alhambra, D European Hlth Data Evidence |
| author_sort | Prats-Uribe, A |
| collection | OXFORD |
| description | |
| first_indexed | 2024-03-06T18:14:36Z |
| format | Conference item |
| id | oxford-uuid:042fe93c-c8e6-425d-97bd-c0df5d2e326d |
| institution | University of Oxford |
| last_indexed | 2024-03-06T18:14:36Z |
| publishDate | 2020 |
| record_format | dspace |
| spelling | oxford-uuid:042fe93c-c8e6-425d-97bd-c0df5d2e326d2022-03-26T08:50:26ZCardio- and cerebrovascular risk with conventional synthetic disease-modifying antirheumatic drugs (CSDMARDS) in rheumatic arthritis (RA): a real-world comparative assesmentConference itemhttp://purl.org/coar/resource_type/c_5794uuid:042fe93c-c8e6-425d-97bd-c0df5d2e326dSymplectic Elements2020Prats-Uribe, AIllingens, BVizcaya, DWeaver, JBurn, ESawant, RMarinier, KRyan, PPrieto-Alhambra, DEuropean Hlth Data Evidence |
| spellingShingle | Prats-Uribe, A Illingens, B Vizcaya, D Weaver, J Burn, E Sawant, R Marinier, K Ryan, P Prieto-Alhambra, D European Hlth Data Evidence Cardio- and cerebrovascular risk with conventional synthetic disease-modifying antirheumatic drugs (CSDMARDS) in rheumatic arthritis (RA): a real-world comparative assesment |
| title | Cardio- and cerebrovascular risk with conventional synthetic disease-modifying antirheumatic drugs (CSDMARDS) in rheumatic arthritis (RA): a real-world comparative assesment |
| title_full | Cardio- and cerebrovascular risk with conventional synthetic disease-modifying antirheumatic drugs (CSDMARDS) in rheumatic arthritis (RA): a real-world comparative assesment |
| title_fullStr | Cardio- and cerebrovascular risk with conventional synthetic disease-modifying antirheumatic drugs (CSDMARDS) in rheumatic arthritis (RA): a real-world comparative assesment |
| title_full_unstemmed | Cardio- and cerebrovascular risk with conventional synthetic disease-modifying antirheumatic drugs (CSDMARDS) in rheumatic arthritis (RA): a real-world comparative assesment |
| title_short | Cardio- and cerebrovascular risk with conventional synthetic disease-modifying antirheumatic drugs (CSDMARDS) in rheumatic arthritis (RA): a real-world comparative assesment |
| title_sort | cardio and cerebrovascular risk with conventional synthetic disease modifying antirheumatic drugs csdmards in rheumatic arthritis ra a real world comparative assesment |
| work_keys_str_mv | AT pratsuribea cardioandcerebrovascularriskwithconventionalsyntheticdiseasemodifyingantirheumaticdrugscsdmardsinrheumaticarthritisraarealworldcomparativeassesment AT illingensb cardioandcerebrovascularriskwithconventionalsyntheticdiseasemodifyingantirheumaticdrugscsdmardsinrheumaticarthritisraarealworldcomparativeassesment AT vizcayad cardioandcerebrovascularriskwithconventionalsyntheticdiseasemodifyingantirheumaticdrugscsdmardsinrheumaticarthritisraarealworldcomparativeassesment AT weaverj cardioandcerebrovascularriskwithconventionalsyntheticdiseasemodifyingantirheumaticdrugscsdmardsinrheumaticarthritisraarealworldcomparativeassesment AT burne cardioandcerebrovascularriskwithconventionalsyntheticdiseasemodifyingantirheumaticdrugscsdmardsinrheumaticarthritisraarealworldcomparativeassesment AT sawantr cardioandcerebrovascularriskwithconventionalsyntheticdiseasemodifyingantirheumaticdrugscsdmardsinrheumaticarthritisraarealworldcomparativeassesment AT marinierk cardioandcerebrovascularriskwithconventionalsyntheticdiseasemodifyingantirheumaticdrugscsdmardsinrheumaticarthritisraarealworldcomparativeassesment AT ryanp cardioandcerebrovascularriskwithconventionalsyntheticdiseasemodifyingantirheumaticdrugscsdmardsinrheumaticarthritisraarealworldcomparativeassesment AT prietoalhambrad cardioandcerebrovascularriskwithconventionalsyntheticdiseasemodifyingantirheumaticdrugscsdmardsinrheumaticarthritisraarealworldcomparativeassesment AT europeanhlthdataevidence cardioandcerebrovascularriskwithconventionalsyntheticdiseasemodifyingantirheumaticdrugscsdmardsinrheumaticarthritisraarealworldcomparativeassesment |